Birdwatch Archive

Birdwatch Note Rating

2023-01-16 15:23:15 UTC - NOT_HELPFUL

Rated by Participant: EDEBB3FAE6FC3423B9F2239553EECF87FCF28B826DE5F8D4E4A75F282C038DFE
Participant Details

Original Note:

Moderna’s $19 billion profit resulted from extremely incompetent pricing agreed to by US govt. There was no reason for the govt to so grossly overpay for a therapeutic for which Moderna did no marketing, incurred no sales expense, got expedited approval and guaranteed sales.

All Note Details

Original Tweet

All Information

  • noteId - 1614845703829725191
  • participantId -
  • raterParticipantId - EDEBB3FAE6FC3423B9F2239553EECF87FCF28B826DE5F8D4E4A75F282C038DFE
  • createdAtMillis - 1673882595375
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 1
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1614845703829725191EDEBB3FAE6FC3423B9F2239553EECF87FCF28B826DE5F8D4E4A75F282C038DFE